Mannatech, Incorporated (NASDAQ:MTEX) Short Interest Down 20.0% in July

Mannatech, Incorporated (NASDAQ:MTEXGet Free Report) was the target of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 400 shares, a drop of 20.0% from the June 30th total of 500 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 1,000 shares, the days-to-cover ratio is presently 0.4 days.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on Mannatech in a report on Monday. They issued a “buy” rating on the stock.

Read Our Latest Report on MTEX

Mannatech Price Performance

Shares of NASDAQ:MTEX traded up $0.28 on Tuesday, hitting $7.67. The company’s stock had a trading volume of 310 shares, compared to its average volume of 1,330. The company has a 50-day simple moving average of $7.38 and a 200 day simple moving average of $8.14. Mannatech has a 1 year low of $6.75 and a 1 year high of $15.10. The company has a market capitalization of $14.42 million, a PE ratio of -8.62 and a beta of 1.17. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.08 and a quick ratio of 0.56.

Mannatech (NASDAQ:MTEXGet Free Report) last released its quarterly earnings results on Tuesday, May 14th. The company reported $0.63 earnings per share for the quarter. Mannatech had a negative return on equity of 15.37% and a negative net margin of 1.31%. The firm had revenue of $29.39 million for the quarter.

Mannatech Company Profile

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Featured Articles

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.